Protalix BioTherapeutics (PLX) Other Working Capital Changes (2010 - 2018)
Protalix BioTherapeutics (PLX) posted quarterly Other Working Capital Changes of $1.7 million for Q2 2024, up 114.05% year-over-year from $773666.2 in Q3 2023, and down 85.0% quarter-over-quarter from $11.0 million in Q1 2024.
Protalix BioTherapeutics (PLX) Other Working Capital Changes (2010 - 2018) Analysis & Trends
Protalix BioTherapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $1.7 million for Q2 2024.
- In Q2 2024, Other Working Capital Changes rose 114.05% year-over-year to $1.7 million; the TTM figure through Jun 2024 stood at $12.7 million (up 171.74% YoY), while the FY2023 annual figure was -$13.2 million, down 84.0% from the prior year.
- Other Working Capital Changes for Q2 2024 stood at $1.7 million, down from $11.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $29.9 million in Q3 2018, with the low at -$2.9 million in Q1 2014.
- The 5-year median for Other Working Capital Changes is $60500.0 (2015), against an average of $4.1 million.
- Peak annual rise in Other Working Capital Changes reached 43141.67% in 2020, while the deepest fall reached 1372.48% in 2020.
- Protalix BioTherapeutics' Other Working Capital Changes stood at -$25.7 million in 2020, then surged by 45.63% to -$14.0 million in 2021, then jumped by 88.46% to -$1.6 million in 2022, then plunged by 630.03% to -$11.8 million in 2023, then surged by 114.05% to $1.7 million in 2024.
- Business Quant data shows PLX's Other Working Capital Changes at $1.7 million in Q2 2024, $11.0 million in Q1 2024, and -$11.8 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 29.90 Mn |
| Sep 30, 2018 | 29.90 Mn |
| Sep 30, 2018 | 29.90 Mn |
| Jun 30, 2018 | 2.86 Mn |
| Jun 30, 2018 | 2.86 Mn |
| Jun 30, 2018 | 2.86 Mn |
| Mar 31, 2018 | 2.18 Mn |
| Mar 31, 2018 | 2.18 Mn |
| Mar 31, 2018 | 2.18 Mn |
| Dec 31, 2017 | 26.85 Mn |
| Dec 31, 2017 | 26.85 Mn |
| Dec 31, 2017 | 26.85 Mn |
| Sep 30, 2017 | -1.93 Mn |
| Sep 30, 2017 | -1.93 Mn |
| Sep 30, 2017 | -1.93 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | -120,000.00 |
| Dec 31, 2016 | -120,000.00 |